Drug Delivery

Drug delivery is the method in which a pharmaceutical compound is administered to promote a therapeutic effect. Drug delivery routes can include oral, transdermal, nasal, and sublingual application and can directly impact a drugs efficacy. In this drug delivery content hub, you can discover editorial coverage of the latest research and industry trends impacting drug delivery and novel drug discovery.

  • Pharmaceutical P.I.N. Points: Patent Innovation News

    The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical arena issued by the US Patent Office in October-November, 2024. read more

  • The Future of Bispecific Antibodies

    After years of research and development, the field of bispecific antibodies (BsAbs) is gaining momentum. More than a dozen bispecific antibodies have secured FDA approval. These new therapies have added much-needed therapeutic value to challenging disease states such as relapsed/refractory multiple myeloma. In 12 months, three distinct CD3-engaging... read more

  • Beyond the Cleanroom: The Human and Technological Edge in Aseptic Manufacturing

    True expertise in aseptic manufacturing is more than knowledge - it is a commitment to adapting practices to keep pace with emerging technologies, diseases, and regulatory requirements. The pharmaceutical industry continuously evolves as it keeps pace with emerging threats to public health, burgeoning technologies, and new regulations, which at ... read more
Page

  • Whitepaper: Key Considerations for Extracting Proteins from Recombinant Host Cells

    In the biopharmaceutical industry, quality is pivotal. For a final product to meet quality standards, quality must be built into the production process. Biopharmaceuticals, however, are made from biologically sourced materials, which are inherently variable. read more

  • eBook: Glass Related Recalls in Pharma

    Typically, drug recalls fall into two categories: recalls issued for the cracking or breaking of glass vials and recalls issued for the presence of particulates being detected in the drug solution. read more

  • Whitepaper: Purification Strategies for Recombinant Therapeutic Proteins

    Many biopharmaceuticals are recombinant proteins obtained by biotechnological processes. In various steps of the pharmaceutical value chain, from drug discovery, to development and manufacturing, to bioprocessing, these proteins must be extracted from their complex biological sources, typically microorganisms or genetically ... read more

  • Whitepaper: Global regulators’ FAQs on CMC in IND/BLA filing

    Mammalian cell cultures used in the manufacturing of therapeutics must be tested to ensure lack of mycoplasmal contamination. Previously, the only test for mycoplasma accepted by regulatory agencies was a culture-based test such as the test detailed in USP <63>. Currently, regulatory agencies globally accept nucleic acid testing ... read more

  • Whitepaper: How to Develop an Efficient Drug Formulation Process

    Developing an efficient drug formulation development process requires expertise. Ascendia Pharmaceuticals, a leading specialty CDMO, has been recognized as a Partner of Choice by many drug companies because they have solved complex formulations for nearly a decade. Ascendia’s white paper details how to implement a drug discovery... read more
Page

Webinars

  • <<
  • >>